Management of Peyronie's disease – a review

被引:0
作者
Hari Siva Gurunadha Rao Tunuguntla
机构
[1] 1624,
[2] SW 40th Terrace,undefined
[3] Apt. D,undefined
[4] Gainesville,undefined
[5] FL 32607–4086,undefined
[6] Florida,undefined
[7] USA e-mail: gurunadharaot@yahoo.com Tel.: +1-352-3841817,undefined
[8] North Florida Urology Research Institute,undefined
[9] 6440,undefined
[10] West Newberry Road,undefined
[11] Suite 410,undefined
[12] Gainesville,undefined
[13] FL 32605,undefined
[14] USA,undefined
来源
World Journal of Urology | 2001年 / 19卷
关键词
Ibuprofen; Colchicine; Erectile Dysfunction; Sexual Intercourse; Scar Tissue;
D O I
暂无
中图分类号
学科分类号
摘要
 Peyronie's disease is an uncommon condition involving middle-aged men and probably resulting from penile trauma. The injury causes an inflammation in the tunica and ultimately scarring and penile curvature develop. It may also occur due to nonspecific inflammation. The use of medications such as β-blockers can sometimes result in Peyronie's disease. In Peyronie's disease, the normal elastic tissue of the tunica is replaced by scar tissue. The penile plaque, or scar tissue in this condition, is not elastic but hard and will not stretch with erection. The side that does not stretch results in penile curvature to the side of the scar. One third of men with Peyronie's disease have painful erections. A low percentage of men with Peyronie's disease develop erectile dysfunction. Because inflammation is initially associated with the scar tissue, some amount of discomfort occurs during erection. Most patients with early stage Peyronie's disease can continue to function sexually with the curvature in the penis. Others with a severe penile deformity will have difficulty in sexual intercourse. Literature regarding the effectiveness of conservative therapy in the early phase with pain and inflammation is limited, with only modest and at times anecdotal benefits. The commonly used agents include 400 units of vitamin E (vitamin E promotes healing and prevents scarring), ibuprofen (anti-inflammatory) and Colchicine (useful for pain during erection). Fexofenadine is recently being used in the early phase of Peyronie's disease for its anti-inflammatory effect. Radiation and ultrasound are not usually very helpful. When the disease process stops, there is usually some residual distortion of the penis but the majority of patients are able to have satisfactory sexual intercourse. However, if there is severe penile distortion interfering with intercourse, surgery is indicated. Surgical techniques for Peyronie's disease include tightening or plication (Nesbit's tuck) of the penis opposite the curvature to produce straightening. This usually results in some small loss of length. The other type of surgery consists of incision of the plaque or scar tissue and patching with a vein (saphenous vein graft) or dermal graft. Laser therapy is occasionally used. A penile prosthesis is the treatment of choice in patients with Peyronie's disease and erectile dysfunction.
引用
收藏
页码:244 / 250
页数:6
相关论文
共 50 条
  • [21] Management of Peyronie's Disease after Collagenase (Xiaflex®)
    Alwaal, Amjad
    Hussein, Ahmed Aly
    Zaid, Uwais B.
    Lue, Tom F.
    CURRENT DRUG TARGETS, 2015, 16 (05) : 484 - 494
  • [22] Peyronie's disease: surgical management: autologous materials
    C C Carson
    J L Chun
    International Journal of Impotence Research, 2002, 14 : 329 - 335
  • [23] Surgical management of complex curvature in Peyronie's disease
    Kadioglu, Ates
    Gurcan, Mehmet
    Rakhmonovich, Abdurakhmonov Farkod
    Dursun, Murat
    WORLD JOURNAL OF UROLOGY, 2024, 42 (01)
  • [24] Contemporary Review of Treatment Options for Peyronie's Disease
    Sherer, Benjamin A.
    Levine, Laurence A.
    UROLOGY, 2016, 95 : 16 - 24
  • [25] Evaluation of Oral Pentoxifylline, Colchicine, and Penile Traction for the Management of Peyronie's Disease
    Ibrahim, Ahmed
    Gazzard, Lauren
    Alharbi, Mohannad
    Rompre-Brodeur, Alexis
    Aube, Melanie
    Carrier, Serge
    SEXUAL MEDICINE, 2019, 7 (04): : 459 - 463
  • [26] Peyronie's disease
    Hauptmann, A.
    Diemer, T.
    Weidner, W.
    UROLOGE, 2011, 50 (05): : 609 - 618
  • [27] 2013-2014 Updates in Peyronie's Disease Management
    Sherer, Benjamin A.
    Warrior, Krishnan
    Levine, Laurence A.
    CURRENT UROLOGY REPORTS, 2014, 15 (12) : 1 - 7
  • [28] Management of Peyronie's Disease During Placement of Penile Prosthesis
    Tonzi, Michael
    Shridharani, Anand
    CURRENT SEXUAL HEALTH REPORTS, 2021, 13 (01) : 23 - 29
  • [29] The association between Peyronie's disease and depression: a scoping review
    Kraglund, Rune
    Durukan, Emil
    Giraldi, Annamaria
    Fode, Mikkel
    SEXUAL MEDICINE REVIEWS, 2024, 12 (02) : 221 - 229
  • [30] Treatment of Peyronie's disease: 2012 update
    Serefoglu E.C.
    Hellstrom W.J.G.
    Current Urology Reports, 2011, 12 (6) : 444 - 452